← Back to Clinical Trials
Recruiting NCT06896370

NCT06896370 An Observational Study for Gastric Cancer in Carriers of High Risk Helicobacter Pylori

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06896370
Status Recruiting
Phase
Sponsor Fudan University
Condition Gastric (Stomach) Cancer
Study Type OBSERVATIONAL
Enrollment 3,000 participants
Start Date 2025-07-01
Primary Completion 2035-05-01

Eligibility & Interventions

Sex All sexes
Min Age 40 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
observational study

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 3,000 participants in total. It began in 2025-07-01 with a primary completion date of 2035-05-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study is intended to be a prospective observational cohort study. The incidence of gastric cancer and progression of gastric precancerous lesions will be compared between groups through prospective follow-up of a population with baseline negative gastric endoscopy, harboring high-risk Hp SNP subtypes and non-high-risk subtypes.

Eligibility Criteria

Inclusion Criteria : 1. Age ≥ 40 years, gender is not limited. 2. Able and willing to provide informed consent and willing to undergo baseline and follow-up examinations. Exclusion Criteria: 1. A history of diagnosed gastric cancer or other malignant tumors of the digestive tract. 2. Comorbid severe underlying conditions (e.g., severe cardiopulmonary insufficiency, liver or renal failure, etc.) that are likely to result in a short life expectancy or render long-term follow-up impractical. 3. Severe mental illness or incapacity to participate in the study due to lack of civil behavior. 4. Pregnant or breastfeeding women. 5. Other conditions that the investigator deems inappropriate for participation in the study.

Contact & Investigator

Central Contact

Dazhi Xu, PhD

✉ xudzh@fudan.edu.cn

📞 86-18121299796

Frequently Asked Questions

Who can join the NCT06896370 clinical trial?

This trial is open to participants of all sexes, aged 40 Years or older, studying Gastric (Stomach) Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06896370 currently recruiting?

Yes, NCT06896370 is actively recruiting participants. Contact the research team at xudzh@fudan.edu.cn for enrollment information.

Where is the NCT06896370 trial being conducted?

This trial is being conducted at Tongling, China.

Who is sponsoring the NCT06896370 clinical trial?

NCT06896370 is sponsored by Fudan University. The trial plans to enroll 3,000 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology